PharmacovigilanceOfficial

Council sets EU position on Denmark–Faroe Islands veterinary protocol implementing provisions

🇪🇺 EUR-Lex · Fri 30 Oct 2026

Council Decision (EU) 2026/2471 fixes the EU stance for the Joint Committee on amending provisions that implement the veterinary protocol to the EU–Denmark/Faroe Islands Agreement.

The Council of the EU has adopted Decision (EU) 2026/2471, dated 12 October 2026, setting the position the Union will take within the Joint Committee established under the Agreement between the European Community, of the one part, and the Government of Denmark and the Home Government of the Faroe Islands, of the other part.

The Joint Committee is due to consider an amendment to the provisions that implement the Protocol on veterinary matters, which supplements that Agreement. The decision was published in EUR-Lex on 30 October 2026.

The material available does not describe what the amendments contain. It is therefore not possible to say from this item alone whether they touch veterinary medicines, pharmacovigilance obligations, or other areas of veterinary trade and controls.

As such, the decision is chiefly an institutional step. It fixes the EU's negotiating line ahead of a decision by the bilateral body, rather than itself introducing new technical requirements.

What it means for your team

  • No direct change to veterinary medicine or pharmacovigilance obligations can be concluded from this item; the substance of the amendments is not stated.
  • Teams with trade links to the Faroe Islands should watch for the Joint Committee's resulting act and any annexes to see whether practical requirements change.
  • Regulatory affairs staff may wish to check the full text of the Council Decision in EUR-Lex before assessing any impact.

Official source: EUR-Lex ↗

Article written by VigiEye from the official source (EUR-Lex). AI-assisted; check the source before acting.

More Pharmacovigilance All →